Low–Estrogen Receptor–Positive Breast Cancer: The Impact of Tissue Sampling, Choice of Antibody, and Molecular Subtyping
Author:
Affiliation:
1. Nottingham University Hospitals National Health Service Trust; and University of Nottingham, Nottingham City Hospital, Nottingham, United Kingdom
2. The Institute of Cancer Research, London, United Kingdom
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.43.2831
Reference17 articles.
1. Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
2. The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast
3. Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)
4. Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma
5. The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer;Modern Pathology;2023-10
2. FOXC1 and SOX10 in Estrogen Receptor–Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction;Archives of Pathology & Laboratory Medicine;2023-06-28
3. Evaluation oncotype DX® 21‐gene recurrence score and clinicopathological parameters: a single institutional experience;Histopathology;2023-02
4. A hierarchical approach to combine histological grade and immunohistochemical factors to identify high-risk luminal breast cancers;ecancermedicalscience;2022-05-04
5. Assessment of Predictive Biomarkers in Breast Cancer: Challenges and Updates;Pathobiology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3